These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31401813)

  • 1. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
    Parkin L; Quon J; Sharples K; Barson D; Dummer J
    Respirology; 2020 Feb; 25(2):173-182. PubMed ID: 31401813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Under-utilisation of β-blockers in patients with acute coronary syndrome and comorbid chronic obstructive pulmonary disease.
    Kratzer L; Noakes P; Baumwol J; Wrobel JP
    Intern Med J; 2018 Aug; 48(8):931-936. PubMed ID: 29573074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome.
    Hadi HA; Zubaid M; Al Mahmeed W; El-Menyar AA; Ridha M; Alsheikh-Ali AA; Singh R; Assad N; Al Habib K; Al Suwaidi J
    Clin Cardiol; 2010 Apr; 33(4):228-35. PubMed ID: 20394044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
    Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
    Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and type of bleeding complications early and late after acute coronary syndrome admission in a New Zealand cohort (ANZACS-QI-7).
    Voss WB; Lee M; Devlin GP; Kerr AJ
    N Z Med J; 2016 Jul; 129(1437):27-38. PubMed ID: 27362596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
    Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
    Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.
    Bezin J; Pariente A; Lassalle R; Dureau-Pournin C; Abouelfath A; Robinson P; Moore N; Droz-Perroteau C; Fourrier-Reglat A
    Eur J Clin Pharmacol; 2014 Apr; 70(4):429-36. PubMed ID: 24271648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
    Awad HH; Zubaid M; Alsheikh-Ali AA; Al Suwaidi J; Anderson FA; Gore JM; Goldberg RJ
    Am J Cardiol; 2011 Nov; 108(9):1252-8. PubMed ID: 21880292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE).
    Kaul U; Sethi KK; Dalal J; Parikh K; Hiremath MS; Mullasari AS; Nair T; Sandhu PS; Kotak B
    Indian Heart J; 2014; 66(3):334-9. PubMed ID: 24973840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.